(Q61908019)

English

Rifaximin-Extended Intestinal Release Induces Remission in Patients With Moderately Active Crohn's Disease

scientific article published in March 2012

In more languages
default for all languages
No label defined

No description defined

Statements

Rifaximin-extended intestinal release induces remission in patients with moderately active Crohn's disease (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit